Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director SUVRETTA CAPITAL MANAGEMENT, LLC
Benitec Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(49.9%),Aaron Cowen(49.9%), etc.
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(8.3%),Janus Henderson Biotech Innovation Master Fund Ltd(6.4%)
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-HBM Healthcare Investments (Cayman) Ltd.(9.7%)
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(13.5%),Janus Henderson Biotech Innovation Master Fund Ltd(10.3%)
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(13.5%)
Benitec Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(49.9%),Aaron Cowen(49.9%), etc.
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Director SUVRETTA CAPITAL MANAGEMENT, LLC
Benitec Biopharma | 3: Initial statement of beneficial ownership of securities-Director Mehta Kishan
Benitec Biopharma | 3: Initial statement of beneficial ownership of securities-10% Owner SUVRETTA CAPITAL MANAGEMENT, LLC
Benitec Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Suvretta Capital Management, LLC(19.99%),Aaron Cowen(19.99%), etc.
Benitec Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-HBM Healthcare Investments (Cayman) Ltd.(9.99%)
Benitec Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Steven M. Oliveira(8.89%),Nemean Asset Management, LLC(8.39%), etc.
Benitec Biopharma | D: Filing D
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(9.99%),Adage Capital Partners GP, L.L.C.(9.99%), etc.
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Boston Megan
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Banks Jerel A.
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.6%),Citadel Advisors LLC(3.4%), etc.
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%), etc.
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.0%),Janus Henderson Biotech Innovation Master Fund Ltd(7.0%)
No Data
No Data